About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 397391, 8 pages
Research Article

Concerted Action of ANP and Dopamine D1-Receptor to Regulate Sodium Homeostasis in Nephrotic Syndrome

1Nephrology Research & Development Unit, Faculty of Medicine, University of Porto & Hospital S. João EPE, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
2Faculty of Dental Medicine, University of Porto, Rua Dr. Manuel Pereira da Silva, 4200-393 Porto, Portugal
3Laboratory of General Physiology, Unit for Multidisciplinary Biomedical Research (UMIB), Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua de Jorge Viterbo Ferreira No. 228, 4050-313 Porto, Portugal
4Renal y Cardiovascular Physiopathology Research Unit, Instituto Reina Sofia de Investigación Nefrológica, Department of Physiology and Pharmacology, University of Salamanca, Edificio Departamental S-20 Campus Miguel de Unamuno, 37007 Salamanca, Spain
5Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL), Research Unit, University Hospital of Salamanca, Paseo de San Vicente 58-182, 37007 Salamanca, Spain

Received 25 April 2013; Revised 23 June 2013; Accepted 24 June 2013

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2013 Cátia Fernandes-Cerqueira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. Humphreys, F. C. Rector Jr., M. G. Cogan et al., “Mechanisms and management of nephrotic edema,” Kidney International, vol. 45, no. 1, pp. 266–281, 1994. View at Scopus
  2. G. Deschênes, M. Wittner, A. Di Stefano, S. Jounier, and A. Doucet, “Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy,” Journal of the American Society of Nephrology, vol. 12, no. 3, pp. 598–601, 2001. View at Scopus
  3. V. Besse-Eschmann, J. Klisic, V. Nief, M. Le Hir, B. Kaissling, and P. M. Ambühl, “Regulation of the proximal tubular sodium/proton exchanger NHE3 in rats with puromycin aminonucleoside (PAN)-induced nephrotic syndrome,” Journal of the American Society of Nephrology, vol. 13, no. 9, pp. 2199–2206, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Plum, Y. Mirzaian, and B. Grabensee, “Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome,” Nephrology Dialysis Transplantation, vol. 11, no. 6, pp. 1034–1042, 1996. View at Scopus
  5. E. Zolty, N. Ibnou-Zekri, S. Izui, E. Féraille, and H. Favre, “Glomerulonephritis and sodium retention: enhancement of Na+ /K+-ATPase activity in the collecting duct is shared by rats with puromycin induced nephrotic syndrome and mice with spontaneous lupus-like glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 14, no. 9, pp. 2192–2195, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-P. Valentin, C. Qiu, W. P. Muldowney, W.-Z. Ying, D. G. Gardner, and M. H. Humphreys, “Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome,” The Journal of Clinical Investigation, vol. 90, no. 4, pp. 1302–1312, 1992. View at Scopus
  7. J.-P. Valentin, W.-Z. Ying, L. A. Sechi et al., “Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis,” Journal of the American Society of Nephrology, vol. 7, no. 4, pp. 582–593, 1996. View at Scopus
  8. A. C. Aperia, “Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism,” Annual Review of Physiology, vol. 62, pp. 621–647, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Soares-da-Silva, “Source and handling of renal dopamine: its physiological importance,” News in Physiological Science, vol. 9, pp. 128–134, 1994.
  10. A. Aperia, A. Bertorello, and I. Seri, “Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments,” American Journal of Physiology, vol. 252, no. 1, pp. F39–F45, 1987. View at Scopus
  11. D. Bacic, B. Kaissling, P. McLeroy, L. Zou, M. Baum, and O. W. Moe, “Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule,” Kidney International, vol. 64, no. 6, pp. 2133–2141, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Hussain and M. F. Lokhandwala, “Renal dopamine receptor function in hypertension,” Hypertension, vol. 32, no. 2, pp. 187–197, 1998. View at Scopus
  13. B. Sampaio-Maia, M. Moreira-Rodrigues, P. Serrão, and M. Pestana, “Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome,” Nephrology Dialysis Transplantation, vol. 21, no. 2, pp. 314–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. S. Hedge, C.-J. Chen, and M. F. Lokhandwala, “Involvement of endogenous dopamine and DA-1 receptors in the renal effects of atrial natriuretic factor in rats,” Clinical and Experimental Hypertension A, vol. 13, no. 3, pp. 357–369, 1991. View at Scopus
  15. M. Martin-Grez, J. P. Briggs, G. Schubert, and J. Schnermann, “Dopamine receptor antagonists inhibit the natriuretic response to atrial natriuretic factor (ANF),” Life Sciences, vol. 36, no. 22, pp. 2171–2176, 1985. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Pettersson, J. Hedner, and T. Hedner, “The diuretic effect of atrial natriuretic peptide (ANP) is dependent on dopaminergic activation,” Acta Physiologica Scandinavica, vol. 126, no. 4, pp. 619–621, 1986. View at Scopus
  17. J. Winaver, J. C. Burnett, G. M. Tyce, and T. P. Dousa, “ANP inhibits Na+-H+ antiport in proximal tubular brush border membrane: role of dopamine,” Kidney International, vol. 38, no. 6, pp. 1133–1140, 1990. View at Scopus
  18. H. Brismar, M. Asghar, R. M. Carey, P. Greengard, and A. Aperia, “Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 10, pp. 5573–5578, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. E. H. Bae, J. U. Lee, S. K. Ma, and S. W. Kim, “Changes of atrial natriuretic peptide system in rats with puromycin aminonucleoside-induced nephrotic syndrome,” Korean Journal of Physiology and Pharmacology, vol. 13, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. H. Correa, M. R. Choi, M. Gironacci, M. S. Valera, and B. E. Fernández, “Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+-ATPase activity,” Regulatory Peptides, vol. 138, no. 1, pp. 26–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A.-C. Eklöf, U. Holtbäck, J. Svennilson, A. Fienberg, P. Greengard, and A. Aperia, “Increased blood pressure and loss of ANP-induced natriuresis in mice lacking DARPP-32 gene,” Clinical and Experimental Hypertension, vol. 23, no. 6, pp. 449–460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Aperia, U. Holtbäck, M.-L. Syrén, L.-B. Svensson, J. Fryckstedt, and P. Greengard, “Activation/deactivation of renal Na+,K+-ATPase: a final common pathway for regulation of natriuresis,” FASEB Journal, vol. 8, no. 6, pp. 436–439, 1994. View at Scopus